Viewing Study NCT00745433


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2025-12-26 @ 1:35 AM
Study NCT ID: NCT00745433
Status: COMPLETED
Last Update Posted: 2023-11-02
First Post: 2008-09-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module